Cargando…
Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study
INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facili...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042590/ https://www.ncbi.nlm.nih.gov/pubmed/29950473 http://dx.doi.org/10.1136/bmjopen-2018-021764 |
_version_ | 1783339186197102592 |
---|---|
author | Garfield, Sara Furniss, Dominic Husson, Fran Turley, Margaret Dean Franklin, Bryony |
author_facet | Garfield, Sara Furniss, Dominic Husson, Fran Turley, Margaret Dean Franklin, Bryony |
author_sort | Garfield, Sara |
collection | PubMed |
description | INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facilitate medication transfer, which may be paper or electronic. However, it is not known how PHIMed should best be used, whether it improves patient outcomes, nor is its key ‘active ingredients’ known. Discussion with patients and carers has highlighted this as a priority for research. We aim to identify how PHIMed is used in practice, barriers and facilitators to its use and key features of PHIMed that support medicines optimisation in practice. METHODS AND ANALYSIS: This study will take place in Greater London, England. We will include patients with long-term conditions, carers and healthcare professionals. The study has four work packages (WPs). WP1 involves qualitative interviews with healthcare professionals (n=16) and focus groups with patients and carers (n=20), including users and non-users of PHIMed, to study perceptions around its role, key features, barriers and facilitators, and any unintended consequences. WP2 will involve documentary analysis of how PHIMed is used, what is documented and read, and by whom, in a stratified sample of 60 PHIMed users. In WP3, we will carry out a descriptive analysis of PHIMed tools used/available, both electronic and paper, and categorise their design and key features based on those identified in WP1/2. Finally, in WP4, findings from WPs 1–3 will be integrated and analysed using distributed cognition as a theoretical framework to explore how information is recorded, transformed and propagated among different people and artefacts. ETHICS AND DISSEMINATION: The study has National Health Service ethics approval. It will provide initial recommendations around the present use of PHIMed to optimise patient care for patients, carers and healthcare professionals. |
format | Online Article Text |
id | pubmed-6042590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-60425902018-07-16 Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study Garfield, Sara Furniss, Dominic Husson, Fran Turley, Margaret Dean Franklin, Bryony BMJ Open Patient-Centred Medicine INTRODUCTION: Risks of poor information transfer across health settings are well documented, particularly for medication. There is also increasing awareness of the importance of greater patient activation. Patients may use various types of patient-held information about medication (PHIMed) to facilitate medication transfer, which may be paper or electronic. However, it is not known how PHIMed should best be used, whether it improves patient outcomes, nor is its key ‘active ingredients’ known. Discussion with patients and carers has highlighted this as a priority for research. We aim to identify how PHIMed is used in practice, barriers and facilitators to its use and key features of PHIMed that support medicines optimisation in practice. METHODS AND ANALYSIS: This study will take place in Greater London, England. We will include patients with long-term conditions, carers and healthcare professionals. The study has four work packages (WPs). WP1 involves qualitative interviews with healthcare professionals (n=16) and focus groups with patients and carers (n=20), including users and non-users of PHIMed, to study perceptions around its role, key features, barriers and facilitators, and any unintended consequences. WP2 will involve documentary analysis of how PHIMed is used, what is documented and read, and by whom, in a stratified sample of 60 PHIMed users. In WP3, we will carry out a descriptive analysis of PHIMed tools used/available, both electronic and paper, and categorise their design and key features based on those identified in WP1/2. Finally, in WP4, findings from WPs 1–3 will be integrated and analysed using distributed cognition as a theoretical framework to explore how information is recorded, transformed and propagated among different people and artefacts. ETHICS AND DISSEMINATION: The study has National Health Service ethics approval. It will provide initial recommendations around the present use of PHIMed to optimise patient care for patients, carers and healthcare professionals. BMJ Publishing Group 2018-06-27 /pmc/articles/PMC6042590/ /pubmed/29950473 http://dx.doi.org/10.1136/bmjopen-2018-021764 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Patient-Centred Medicine Garfield, Sara Furniss, Dominic Husson, Fran Turley, Margaret Dean Franklin, Bryony Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title | Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title_full | Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title_fullStr | Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title_full_unstemmed | Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title_short | Use of patient-held information about medication (PHIMed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
title_sort | use of patient-held information about medication (phimed) to support medicines optimisation: protocol for a mixed-methods descriptive study |
topic | Patient-Centred Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042590/ https://www.ncbi.nlm.nih.gov/pubmed/29950473 http://dx.doi.org/10.1136/bmjopen-2018-021764 |
work_keys_str_mv | AT garfieldsara useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy AT furnissdominic useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy AT hussonfran useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy AT turleymargaret useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy AT deanfranklinbryony useofpatientheldinformationaboutmedicationphimedtosupportmedicinesoptimisationprotocolforamixedmethodsdescriptivestudy |